Improvement in cardiometabolic risk markers following a multifunctional diet is associated with gut microbial taxa in healthy overweight and obese subjects.

Purpose: A multifunctional diet (MFD) targeting subclinical inflammation was developed as a tool to decrease risk factors for cardiometabolic disease in healthy “at-risk” individuals (BMI 25-33 kg/m2). MFD contains several components that are degraded in the colon by the microbiota, such as dietary...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Nutrition Vol. 57; no. 8; pp. 2927 - 2937
Autores principales: Marungruang, Nittaya, Tovar, Juscelino, Björck, Inger, Hållenius, Frida Fåk
Formato: research Journal Article
Publicado: Springer Nature Dec2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133123970&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 133123970
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14366207
        CR0
      jtl: European Journal of Nutrition
      issn: 14366207
      maglogo: N
    pubinfo:
      dt: Dec2018
      vid: 57
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        133123970
        133123970
        133123970
        10.1007/s00394-017-1563-3
        133123970
      ppf: 2927
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Improvement in cardiometabolic risk markers following a multifunctional diet is associated with gut microbial taxa in healthy overweight and obese subjects.
      aug:
        au:
          Marungruang, Nittaya
          Tovar, Juscelino
          Björck, Inger
          Hållenius, Frida Fåk
        affil: Department of Food Technology, Engineering and Nutrition, Lund University, Kemicentrum, Sölvegatan 39, SE-22100, Lund, Sweden
      sug:
        subj:
          Cardiovascular Risk Factors
          Obesity
          Gut Microbiota Analysis
          Dietary Supplementation
          Biological Markers
          Human
          Middle Age
          Aged
          Body Mass Index
          Sequence Analysis Methods
          RNA Analysis
          Gram-Negative Anaerobic Bacteria
          Blood Pressure
          Faecalibacterium
          Lipids Blood
          Middle Aged: 45-64 years
          Aged: 65+ years
      ab: Purpose: A multifunctional diet (MFD) targeting subclinical inflammation was developed as a tool to decrease risk factors for cardiometabolic disease in healthy “at-risk” individuals (BMI 25-33 kg/m2). MFD contains several components that are degraded in the colon by the microbiota, such as dietary fibers from rye, barley, oats and berries. It also contains soy beans, oily fish and plant stanols. In previous studies, we have observed improved cardiometabolic markers in healthy at-risk individuals after 4-8 week intake of MFD. However, whether these improvements can be associated with changes in the gut microbiota composition has not been investigated. In the present study, we analyzed the gut microbiota before and after an 8-week dietary intervention with MFD.Methods: Cardiometabolic at-risk individuals (n = 47), between 51 and 72 years old and with a BMI of 25-33 kg/m2, were given either the MFD or a control diet lacking the functional (“active”) components for 8 weeks in a parallel, randomized design. Next-generation sequencing of bacterial 16S rRNA genes was used to analyze the gut microbiota composition.Results: The 8-week intervention with MFD did not significantly alter the gut microbiota composition at phylum or genus taxonomic levels, while LEfSE analysis identified increased abundance of Prevotella copri in the MFD group as compared to the control group. Treponema correlated positively with blood pressure. In contrast, Faecalibacterium showed a negative association with blood pressure, while Bilophila appeared to associate with a negative blood lipid profile.Conclusions: Taken together, results from the present study may be used in the further development of effective dietary concepts capable of reducing cardiometabolic risk markers in humans through a targeted modulation of the gut microbial community.Trial registration number: Clinical Trials.gov NCT02148653.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N